Publications by authors named "R Jagadeesh Kannan"

Background: Hemoptysis, the expectoration of blood from the lower respiratory tract, varies in severity and necessitates effective management to mitigate morbidity. Traditional treatments include bronchial artery embolization and pharmacological approaches. Tranexamic acid (TXA), an antifibrinolytic agent known for its efficacy in reducing bleeding during surgery and trauma, is being explored for its efficacy in treating Hemoptysis via both intravenous and inhalational routes.

View Article and Find Full Text PDF

Cement ball mills in the finishing stage of the cement industries consume the highest energy in the cement manufacturing stage. Therefore, suitable controllers that result in good productivity and product quality with reduced energy consumption are required for the cement ball mill grinding process to increase the profit margins. In this study, generalised predictive controllers (GPC)have been designed for the cement ball mill grinding operation using the model obtained from the step response data taken from the industrially recognized simulator.

View Article and Find Full Text PDF

Macrophage efferocytosis (clearance of apoptotic cells) is crucial for tissue homeostasis and wound repair, where macrophages secrete factors that promote resolution of inflammation and regenerative signalling. This study examined the role of efferocytic macrophage-associated CCL2 secretion, its influence on mesenchymal stem/progenitor cell (MSPC) chemotaxis, and in vivo cell recruitment using Ccr2 (KO) mice with disrupted CCL2 receptor signalling in two regenerative models: ossicle implants and ulnar stress fractures. Single cell RNA sequencing and PCR validation indicated that efferocytosis of various apoptotic cells at bone injury sites (osteoblasts, pre-osteoblasts, MSPC) upregulated CCL2.

View Article and Find Full Text PDF

Oral cancer is one of the most common cancers seen in the Indian subcontinent. Its primary treatment is surgery with or without adjuvant treatment. Despite advances in science, prognosis and overall survival has not yet chanced over the past two decades.

View Article and Find Full Text PDF
Article Synopsis
  • * A new glucose-dendrimer (GD2) was developed to selectively target hyperexcitable neurons, which showed promising results in various models, including lab cultures and live mice.
  • * By linking GD2 with the anti-epileptic drug valproic acid (GD2-VPA) and delivering it intranasally, researchers achieved a significant reduction in seizure severity, indicating potential for targeted neuroprotection and improved neuronal health.
View Article and Find Full Text PDF